Pilot study of the effect of lipophilic vs. hydrophilic beta-adrenergic blockers being taken at time of intracardiac defibrillator discharge on subsequent PTSD symptoms

Neurobiology of Learning and Memory

Volumn 112, Issue , 2014, Pages 248-252

  Bhuvaneswar, Chaya G ^a   Ruskin, Jeremy N ^b   Katzman, Anna Roglieri ^b   Wood, Nellie ^b   Pitman, Roger K ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adrenergic beta antagonists (all MeSH terms); Memory; Post traumatic; Secondary prevention; Stress disorders

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; METOPROLOL; PROPRANOLOL; SOTALOL;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CHECKLIST; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HUMAN; HYDROPHILICITY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; LIPOPHILICITY; MALE; MIDDLE AGED; PILOT STUDY; POST TRAUMATIC STRESS DISORDER CHECK LIST; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGIC TEST; RETROSPECTIVE STUDY; VERY ELDERLY; CHEMICAL PHENOMENA; CLASSIFICATION; COMPARATIVE STUDY; STRESS DISORDERS, POST-TRAUMATIC;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; DEFIBRILLATORS, IMPLANTABLE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MALE; MIDDLE AGED; PILOT PROJECTS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84901911798     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2013.12.013     Document Type: Article

References (31)

1. Al-Khatib S.M., Hellkamp A., Bardy G.H., Hammill S., Hall W.J., Mark D.B., et al. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA 2013, 309:55-62.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Press, Washington, D.C. 4th ed.
3. Baumert J., Schmitt C., Ladwig K.H. Psychophysiologic and affective parameters associated with pain intensity of cardiac cardioverter defibrillator shock discharges. Psychosomatic Medicine 2006, 68:591-597.
4. Cahill L., Pham C.A., Setlow B. Impaired memory consolidation in rats produced with beta-adrenergic blockade. Neurobiology of Learning and Memory 2000, 74:259-266.
5. Cahill L., Prins B., Weber M., McGaugh J.L. Beta-adrenergic activation and memory for emotional events. Nature 1994, 371:702-704.
6. Durazo S.A., Kadam R.S., Drechsel D., Patel M., Kompella U.B. Brain mitochondrial drug delivery: Influence of drug physicochemical properties. Pharmaceutical Research 2011, 28:2833-2847.
7. Ford J., Sears S.F., Shea J.B., Cahill J. Cardiology patient page. Coping with trauma and stressful events as a patient with an implantable cardioverter-defibrillator. Circulation 2013, 127:e426-e430.
8. Gazarini L., Stern C.A., Carobrez A.P., Bertoglio L.J. Enhanced noradrenergic activity potentiates fear memory consolidation and reconsolidation by differentially recruiting alpha1- and beta-adrenergic receptors. Learning and Memory 2013, 20:210-219.
9. Hoge E.A., Worthington J.J., Nagurney J.T., Chang Y., Kay E.B., Feterowski C.M., et al. Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neuroscience & Therapeutics 2012, 18:21-27.
10. Introini-Collison I.B., Baratti C.M. Opioid peptidergic systems modulate the activity of beta-adrenergic mechanisms during memory consolidation processes. Behavioral and Neural Biology 1986, 46:227-241.
11. Irvine J., Firestone J., Ong L., Cribbie R., Dorian P., Harris L., et al. A randomized controlled trial of cognitive behavior therapy tailored to psychological adaptation to an implantable cardioverter defibrillator. Psychosomatic Medicine 2011, 73:226-233.
12. Kardos A., Long V., Bryant J., Singh J., Sleight P., Casadei B. Lipophilic versus hydrophilic beta(1) blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction. Heart 1998, 79:153-160.
13. Krauseneck T., Padberg F., Roozendaal B., Grathwohl M., Weis F., Hauer D., et al. A beta-adrenergic antagonist reduces traumatic memories and PTSD symptoms in female but not in male patients after cardiac surgery. Psychological Medicine 2010, 40:861-869.
14. Ladwig K.H., Baumert J., Marten-Mittag B., Kolb C., Zrenner B., Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Archives of General Psychiatry 2008, 65:1324-1330.
15. Lopez-Sendon J., Swedberg K., McMurray J., Tamargo J., Maggioni A.P., Dargie H., et al. Expert consensus document on beta-adrenergic receptor blockers. European Heart Journal 2004, 25:1341-1362.
16. McGaugh J.L. Making lasting memories: Remembering the significant. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(Suppl. 2):10402-10407.
17. Nugent N.R., Christopher N.C., Crow J.P., Browne L., Ostrowski S., Delahanty D.L. The efficacy of early propranolol administration at reducing PTSD symptoms in pediatric injury patients: A pilot study. Journal of Traumatic Stress 2010, 23:282-287.
18. O'Carroll R.E., Drysdale E., Cahill L., Shajahan P., Ebmeier K.P. Stimulation of the noradrenergic system enhances and blockade reduces memory for emotional material in man. Psychological Medicine 1999, 29:1083-1088.
19. Orr S.P., Pitman R.K., Lasko N.B., Herz L.R. Psychophysiological assessment of posttraumatic stress disorder imagery in World War II and Korean combat veterans. Journal of Abnormal Psychology 1993, 102:152-159.
20. Pitman R.K. Post-traumatic stress disorder, hormones, and memory. Biological Psychiatry 1989, 26:221-223.
21. Pitman R.K., Sanders K.M., Zusman R.M., Healy A.R., Cheema F., Lasko N.B., et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biological Psychiatry 2002, 51:189-192.
22. Prudente L.A., Reigle J., Bourguignon C., Haines D.E., DiMarco J.P. Psychological indices and phantom shocks inpatientswith ICD. Journal of Interventional Cardiac Electrophysiology 2006, 15:185-190.
23. Ravindran L., Stein M.B. Pharmacotherapy of post-traumatic stress disorder. Current Topics in Behavioral Neurosciences 2010, 2:505-525.
24. Robinson M.J., Franklin K.B. Central but not peripheral beta-adrenergic antagonism blocks reconsolidation for a morphine place preference. Behavioural Brain Research 2007, 182:129-134.
25. Roozendaal B., McGaugh J.L. Memory modulation. Behavioral Neuroscience 2011, 125:797-824.
26. Roozendaal B., Okuda S., Van der Zee E.A., McGaugh J.L. Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6741-6746.
27. Sears S.E., Conti J.B. Understanding implantable cardioverter defibrillator shocks and storms: Medical and psychosocial considerations for research and clinical care. Clinical Cardiology 2003, 26:107-111.
28. Stein M.B., Kerridge C., Dimsdale J.E., Hoyt D.B. Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients. Journal of Traumatic Stress 2007, 20:923-932.
29. Vaiva G., Ducrocq F., Jezequel K., Averland B., Lestavel P., Brunet A., et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biological Psychiatry 2003, 54:947-949.
30. Weathers F., Litz B.T., Huska J.A., Keane T.M. PTSD Checklist-Specific 1994, National Center for PTSD-Behavioral Sciences Division, Boston.
31. Wilkins K.C., Lang A.J., Norman S.B. Synthesis of the psychometric properties of the PTSD Checklist (PCL) military, civilian, and specific versions. Depression and Anxiety 2011, 28:596-606.